Executive Summary
Apple successfully challenged Omni MedSci’s wearable health‑monitoring patent. The PTAB affirmed the claim construction and held all 23 claims obvious over prior art. No further briefing was authorized.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in SAMSUNG ELECTRONICS CO., LTD. et al. vs OMNI MEDSCI, INC. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Microsoft CorporationvsProxense, LLC
Microsoft has filed a petition for inter partes review of Proxense’s ’730 biometric authentication patent, asserting obviousness over the Ludtke and Kon references and arguing that discretionary denial is unwarranted. The petition seeks institution of the IPR and cancellation of all challenged claims.
Jumio CorporationvsFaceTec, Inc.
The PTAB granted institution for Jumio Corporation's IPR against FaceTec, Inc.'s facial recognition patent (11,157,606). The Board found a reasonable likelihood of success regarding obviousness over prior art references like Derakhshani and Zhang.
Ericsson Inc. et al.vsActive Wireless Technologies LLC
Ericsson and Nokia settled their IPR disputes with Active Wireless Technologies, leading the PTAB to terminate the three pending reviews and keep the settlement agreements confidential.
Tommy John, Inc.vsPakage Apparel, Inc.
Tommy John, Inc. successfully petitioned to invalidate key claims of Pakage Apparel's '974 patent based on obviousness over prior art combinations (Kitsch/Brocks). The PTAB declined discretionary denial because the petitioner showed a reasonable likelihood of prevailing and failed to demonstrate material error in prosecution history.
Samsung Electronics Co., Ltd. et al.vsW&Wsens Devices Inc.
Samsung petitions the PTAB to invalidate W&Wsens' 12,243,948 patent covering microstructured photodetectors, asserting obviousness over Kuboi, Vasylyev and Shinohara and lack of enablement.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.